Drugs / Aflurax
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00184522 | Aug 2002 → Nov 2004 | gastroesophageal reflux disease | Norwegian University of Science and Technology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aflurax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00184522 ↗ |
| Modality | Other / unclassified | “pectin-containing natural product (Aflurax)” NCT00184522 ↗ |